Frequently Asked Questions
Factors such as rising awareness and rising demand for oral drugs are acting as the major drivers for the global poliomyelitis market.
The major companies operating in this market are Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Sanofi (France), Boehringer Ingelheim International GmbH. (Germany), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (U.S.), Astellas Pharma Inc. (Japan).
The major countries covered in the Poliomyelitis Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Type (Nonparalytic Polio, Nonparalytic Polio, Post-Polio Syndrome), Treatment (Medication, Vaccination, Supportive Treatments, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) are covered in Poliomyelitis Market report.
